Efficacy of Intravenous Levetiracetam in Neonatal Seizures
Status:
Completed
Trial end date:
2019-07-31
Target enrollment:
Participant gender:
Summary
A new anticonvulsant, levetiracetam will be studied to treat seizures in newborn infants.
Current treatments for the brain damaging complication of neonatal seizures are
unsatisfactory.
Monitoring for seizure detection will be tested at five (5) US sites and one (1)
international site using the internet.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Richard H. Haas
Collaborators:
Auckland City Hospital Food and Drug Administration (FDA) Loma Linda University Rady Children's Hospital, San Diego Sharp Mary Birch Hospital for Women & Newborns Sharp Mary Birch Hospital for Women & Newborns, San Diego, CA UCSF Benioff Children's Hospital Oakland UCSF Benioff Children's Hospital Oakland, Oakland, CA University of California, San Diego